Cardiac Surgery Instruments Market Size, Share, Growth, and Industry Analysis, By Type (Forceps, Vascular Forceps, Grasping Forceps, Needle Holders, Scissors, Clamps, Other), By Application (Coronary Artery Bypass Graft (CABG), Heart Valve Surgery, Pediatric Cardiac Surgery, Other), Regional Insights and Forecast to 2035

Cardiac Surgery Instruments Market Overview

The global Cardiac Surgery Instruments Market size is projected to grow from USD 1594.23 million in 2026 to USD 1672.35 million in 2027, reaching USD 2466.75 million by 2035, expanding at a CAGR of 4.9% during the forecast period.

The global Cardiac Surgery Instruments Market is driven by increasing cardiac disorders, with over 523 million patients affected globally. The rise in cardiovascular surgeries, which exceeded 11 million in 2024, has boosted the demand for instruments such as forceps, clamps, scissors, and needle holders. Over 1,200 research institutes are focusing on developing advanced surgical tools with improved precision and durability. The integration of robotic-assisted systems has also improved surgery outcomes, with a 19% reduction in operation time and a 22% increase in success rates globally.

In the United States, the Cardiac Surgery Instruments Market dominates due to the presence of more than 4,500 cardiac care centers and 2,000 specialized hospitals. Over 400,000 open-heart surgeries are performed annually in the country, and robotic-assisted procedures represent nearly 32% of all cardiac operations. Advancements in material science and high-precision surgical instruments have increased efficiency by 28% across U.S. hospitals, strengthening the country’s leadership in the global cardiac surgery segment.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Increasing incidence of coronary artery disease boosts demand for surgical instruments by 47.8%.
• Major Market Restraint: High equipment costs and sterilization expenses limit adoption by 32.5% of small hospitals.
• Emerging Trends: Rise in robotic-assisted surgeries observed at a rate of 28.9% annually.
• Regional Leadership: North America dominates the market with a 41.6% share of global demand.
• Competitive Landscape: Top five manufacturers collectively account for 62.4% of total instrument supply.
• Market Segmentation: Surgical scissors and clamps together represent 38.7% of total instrument usage.
• Recent Development: Integration of AI-based surgical tools increased by 24.3% over the past two years.

Cardiac Surgery Instruments Market Latest Trends

The Cardiac Surgery Instruments Market Trends highlight the growing use of minimally invasive and robotic-assisted techniques in cardiac procedures. Over 31% of cardiac surgeries worldwide are now performed using minimally invasive approaches, reducing hospital stays by an average of 4 days. Precision-engineered instruments, such as titanium clamps and micro-forceps, are used in more than 36% of complex procedures. The growing adoption of endoscopic and electrosurgical devices has reduced surgery duration by 18% and improved safety standards by 25%. More than 55% of major hospitals have increased budget allocations for cardiac instrument upgrades, while lightweight and ergonomic tools have improved surgeon comfort by 33%.

Cardiac Surgery Instruments Market Dynamics

DRIVER

"Rising prevalence of cardiovascular diseases"

The key driver of the Cardiac Surgery Instruments Market Growth is the increasing global burden of cardiovascular diseases, responsible for 19.6 million deaths each year. More than 7,800 cardiac operation centers worldwide are performing complex heart surgeries that require high-precision surgical instruments. The shift toward hybrid cardiac operations, combining open-heart and catheter-based techniques, has increased the usage of advanced instruments by 22.5% in Europe and Asia-Pacific. Enhanced training programs and rising investments in cardiac research centers, totaling over 900 new programs globally, are further boosting the market demand.

RESTRAINT

"High cost and limited accessibility of advanced instruments"

The Cardiac Surgery Instruments Industry Report indicates that high manufacturing and maintenance costs are major restraints for smaller healthcare facilities. Advanced robotic-compatible and electrosurgical instruments can cost up to 60% more than standard tools. The sterilization, calibration, and compliance processes increase hospital expenditure by 25.4% annually. Limited funding in developing nations and insufficient technical training have also hindered the adoption of sophisticated equipment. As a result, nearly 32% of hospitals in low-income countries continue to use outdated cardiac surgery instruments, reducing overall surgical efficiency.

OPPORTUNITY

"Technological advancements and automation in surgical instruments"

The Cardiac Surgery Instruments Market Research Report shows expanding opportunities in automation, robotics, and smart surgical devices. Over 480 hospitals worldwide have adopted robotic-assisted cardiac systems, leading to a 37% increase in demand for precision-compatible tools. Smart instruments embedded with sensors for real-time feedback are being introduced across 60% of new cardiac operating rooms. Rapid healthcare investments in Asia-Pacific and Latin America, exceeding the equivalent of USD 200 billion, are supporting innovation in cardiac tools. The introduction of laser-guided and AI-integrated instruments has improved accuracy rates by 29%, creating strong growth potential for manufacturers.

CHALLENGE

"Stringent regulatory frameworks and product validation"

The Cardiac Surgery Instruments Market Analysis highlights regulatory challenges as a major market barrier. The approval and certification process for new instruments can extend up to 24 months, delaying product launches. Compliance with international standards such as FDA, CE, and ISO 13485 increases production costs by 17.6%. Regional regulatory disparities further complicate market entry, with a 15% decline in approval speed between North America and Asia. Additionally, rigorous quality testing and safety assessments slow down innovation cycles, impacting smaller manufacturers’ ability to compete globally.

Cardiac Surgery Instruments Market Segmentation 

The Cardiac Surgery Instruments Market is segmented by type and application to deliver a clear understanding of industry structure and product utilization. By type, the market includes forceps, vascular forceps, grasping forceps, needle holders, scissors, clamps, and other instruments, collectively representing an estimated global market size of USD 1.74 billion in 2024, with a total market share of 100% across segments. By application, the market covers coronary artery bypass graft (CABG), heart valve surgery, pediatric cardiac surgery, and other cardiac procedures, valued collectively at USD 2.12 billion in 2024. Each segment displays varying growth rates ranging between 4.2% and 6.3% CAGR from 2024 to 2032.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Forceps: Forceps are among the most frequently used cardiac surgical instruments, essential for tissue manipulation and grafting. The segment reached an estimated market size of USD 330 million in 2024, accounting for 19% global share.

Forceps Market Size, Share and CAGR: The forceps segment held a market size of USD 330 million in 2024, capturing a 19% share globally and expected to grow at a CAGR of 5.2% through 2032.

Top 5 Major Dominant Countries in the Forceps Segment

• United States: Market Size USD 105 million, Share 31%, CAGR 5.4% driven by over 400,000 annual heart surgeries.
• Germany: Market Size USD 46 million, Share 14%, CAGR 4.7% from strong surgical infrastructure.
• Japan: Market Size USD 40 million, Share 12%, CAGR 4.9% fueled by hybrid surgeries.
• China: Market Size USD 36 million, Share 11%, CAGR 5.8% due to 1.3 million annual cardiac procedures.
• India: Market Size USD 26 million, Share 8%, CAGR 6.1% supported by hospital investments.

Vascular Forceps: Vascular forceps are designed for vessel manipulation, ensuring blood flow control during operations. The segment achieved a market size of USD 245 million in 2024, representing 14% of the total industry.

Vascular Forceps Market Size, Share and CAGR: The vascular forceps segment stood at USD 245 million, accounting for 14% of total market share, with a forecast CAGR of 5.5% until 2032.

Top 5 Major Dominant Countries in the Vascular Forceps Segment

• United States: Market Size USD 69 million, Share 28%, CAGR 5.1% driven by CABG procedures.
• Germany: Market Size USD 39 million, Share 16%, CAGR 4.6% from rising microvascular repairs.
• Japan: Market Size USD 29 million, Share 12%, CAGR 4.9% due to surgical advancements.
• China: Market Size USD 25 million, Share 10%, CAGR 5.7% amid procedural expansion.
• Brazil: Market Size USD 20 million, Share 8%, CAGR 4.4% with healthcare modernization.

Grasping Forceps: Grasping forceps are essential for holding cardiac tissues and grafts during operations. The global segment recorded a market size of USD 210 million in 2024, representing 12% of the total.

Grasping Forceps Market Size, Share and CAGR: The grasping forceps market stood at USD 210 million, capturing 12% share and expected to register a CAGR of 5.1% by 2032.

Top 5 Major Dominant Countries in the Grasping Forceps Segment

• United States: Market Size USD 63 million, Share 30%, CAGR 5.0% due to hybrid operations.
• United Kingdom: Market Size USD 27 million, Share 13%, CAGR 4.8% led by hospital modernization.
• Japan: Market Size USD 25 million, Share 12%, CAGR 5.3% supported by high-precision surgeries.
• China: Market Size USD 21 million, Share 10%, CAGR 5.9% from robotics expansion.
• France: Market Size USD 17 million, Share 8%, CAGR 4.7% through procedural optimization.

Needle Holders: Needle holders are critical in cardiac suturing and valve repair procedures. The segment reached USD 280 million in 2024, holding 16% global market share.

Needle Holders Market Size, Share and CAGR: The needle holders market recorded USD 280 million size, with a 16% share globally and projected CAGR of 5.4% through 2032.

Top 5 Major Dominant Countries in the Needle Holders Segment

• United States: Market Size USD 81 million, Share 29%, CAGR 5.2% from high surgical volume.
• Germany: Market Size USD 39 million, Share 14%, CAGR 4.6% aided by R&D activity.
• Japan: Market Size USD 36 million, Share 13%, CAGR 5.0% supported by valve repair demand.
• China: Market Size USD 28 million, Share 10%, CAGR 5.9% driven by hospital expansion.
• India: Market Size USD 23 million, Share 8%, CAGR 6.2% with cardiac care infrastructure growth.

Scissors: Scissors are used for tissue dissection and precision cutting during heart operations. The segment accounted for USD 175 million in 2024, representing 10% of the total market.

Scissors Market Size, Share and CAGR: The scissors segment reached USD 175 million, holding 10% global share and is projected to grow at a CAGR of 4.9% by 2032.

Top 5 Major Dominant Countries in the Scissors Segment

• United States: Market Size USD 47 million, Share 27%, CAGR 5.0% from high procedural usage.
• Germany: Market Size USD 26 million, Share 15%, CAGR 4.5% led by R&D initiatives.
• Japan: Market Size USD 21 million, Share 12%, CAGR 5.1% via ergonomic improvements.
• China: Market Size USD 19 million, Share 11%, CAGR 5.4% through increased imports.
• France: Market Size USD 16 million, Share 9%, CAGR 4.6% with elevated surgery rates.

Clamps: Clamps are vital for controlling blood flow in cardiac surgeries. The segment accounted for USD 365 million in 2024, holding the largest 21% market share.

Clamps Market Size, Share and CAGR: The clamps segment recorded USD 365 million, with 21% global share, expanding at an estimated CAGR of 5.6% through 2032.

Top 5 Major Dominant Countries in the Clamps Segment

• United States: Market Size USD 120 million, Share 33%, CAGR 5.6% with dominant hospital adoption.
• Germany: Market Size USD 51 million, Share 14%, CAGR 4.8% driven by innovation.
• Japan: Market Size USD 47 million, Share 13%, CAGR 5.0% in robotic-compatible designs.
• China: Market Size USD 37 million, Share 10%, CAGR 5.7% with procedural growth.
• India: Market Size USD 29 million, Share 8%, CAGR 6.0% through infrastructure improvement.

Other Instruments: Other instruments include retractors, dilators, and cannulas used in heart surgeries. The segment reached USD 140 million in 2024, accounting for 8% global share.

Other Instruments Market Size, Share and CAGR: The segment was valued at USD 140 million, holding 8% market share, with an estimated CAGR of 5.1% during 2024–2032.

Top 5 Major Dominant Countries in the Other Instruments Segment

• United States: Market Size USD 36 million, Share 26%, CAGR 4.8% from retraction device demand.
• Germany: Market Size USD 20 million, Share 14%, CAGR 4.5% through procedural efficiency.
• China: Market Size USD 18 million, Share 13%, CAGR 5.5% from local production rise.
• Japan: Market Size USD 17 million, Share 12%, CAGR 5.0% aided by robotic use.
• India: Market Size USD 13 million, Share 9%, CAGR 6.1% through cardiac care development.

BY APPLICATION

Coronary Artery Bypass Graft (CABG): CABG is the largest application, accounting for nearly 46% of total market demand, with an estimated market size of USD 975 million in 2024.

Market Size, Share and CAGR: CABG segment recorded USD 975 million, representing 46% global share with a CAGR of 5.4% projected through 2032.

• United States: Market Size USD 293 million, Share 30%, CAGR 5.4% supported by 400,000 CABG cases yearly.
• Germany: Market Size USD 136 million, Share 14%, CAGR 4.8% with expanding cardiac infrastructure.
• Japan: Market Size USD 117 million, Share 12%, CAGR 5.1% due to growing elderly population.
• China: Market Size USD 107 million, Share 11%, CAGR 5.6% with increasing surgeries.
• India: Market Size USD 88 million, Share 9%, CAGR 6.0% from tertiary hospital expansion.

Heart Valve Surgery: Heart valve surgery represents 28% of the market, with a 2024 market size of USD 595 million.

Market Size, Share and CAGR: The heart valve surgery segment was valued at USD 595 million, accounting for 28% market share with CAGR of 5.2% up to 2032.

• United States: Market Size USD 167 million, Share 28%, CAGR 5.0% through advanced valve repair systems.
• Germany: Market Size USD 89 million, Share 15%, CAGR 4.6% from enhanced cardiac programs.
• Japan: Market Size USD 71 million, Share 12%, CAGR 5.2% supported by robotic valve replacements.
• China: Market Size USD 60 million, Share 10%, CAGR 5.6% via healthcare modernization.
• France: Market Size USD 48 million, Share 8%, CAGR 4.5% under expanding valve replacement projects.

Pediatric Cardiac Surgery: Pediatric cardiac surgery accounts for 11% of the total market, valued at USD 235 million in 2024, addressing congenital and structural heart defects in children.

Market Size, Share and CAGR: The pediatric cardiac surgery segment held USD 235 million, capturing 11% market share with CAGR of 5.8% by 2032.

• United States: Market Size USD 75 million, Share 32%, CAGR 5.2% with specialized pediatric facilities.
• Germany: Market Size USD 31 million, Share 13%, CAGR 4.8% from enhanced pediatric programs.
• Japan: Market Size USD 28 million, Share 12%, CAGR 5.0% driven by surgical innovation.
• India: Market Size USD 24 million, Share 10%, CAGR 5.9% due to increased hospital expansion.
• China: Market Size USD 21 million, Share 9%, CAGR 5.7% supported by new children’s hospitals.

Other Applications: Other applications, including heart transplantation, arrhythmia surgery, and aortic repair, represent 15% of global market value, amounting to USD 315 million in 2024.

Market Size, Share and CAGR: Other applications segment was valued at USD 315 million, covering 15% market share, with a CAGR of 5.0% during 2024–2032.

• United States: Market Size USD 91 million, Share 29%, CAGR 4.9% from transplant surgery volume.
• Germany: Market Size USD 47 million, Share 15%, CAGR 4.5% driven by aortic repair programs.
• Japan: Market Size USD 41 million, Share 13%, CAGR 5.0% with arrhythmia surgery advancements.
• China: Market Size USD 35 million, Share 11%, CAGR 5.5% supported by hospital growth.
• India: Market Size USD 28 million, Share 9%, CAGR 6.0% with multi-specialty expansion.

Cardiac Surgery Instruments Market Regional Outlook 

The global Cardiac Surgery Instruments Market demonstrates strong regional diversification, with North America leading at 41.6% share, followed by Europe at 27.5%, Asia-Pacific at 22.1%, and the Middle East & Africa at 8.8%. North America’s dominance stems from technological leadership, advanced surgical facilities, and high procedural volume exceeding 1.1 million surgeries annually. Europe benefits from its robust healthcare network and clinical innovations, while Asia-Pacific is rapidly expanding due to government investments and growing cardiovascular disease prevalence. The Middle East & Africa region shows steady progress with a focus on healthcare modernization and international collaborations to enhance cardiac surgical capacity across emerging economies.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds a dominant position in the global Cardiac Surgery Instruments Market, accounting for approximately 41.6% of total market share. With over 4,500 cardiac care centers and 2,000 specialized surgical hospitals, the region performs around 1.1 million cardiac operations annually. Adoption of robotic and AI-assisted surgical tools has enhanced procedural precision and reduced operating time by 23%. The demand for minimally invasive surgical devices continues to grow, supported by advanced clinical research and innovation hubs in the United States and Canada. Rising government funding, robust healthcare infrastructure, and an increase in patient awareness are further strengthening market penetration.

North America Market Size, Share, and CAGR: North America recorded a market size of USD 1.02 billion in 2024, capturing a 41.6% share globally, with a projected CAGR of 5.3% from 2024 to 2032.

North America - Major Dominant Countries

• United States: Market Size USD 725 million, Share 71%, CAGR 5.4% driven by over 400,000 annual cardiac procedures and highest use of robotic instruments.
• Canada: Market Size USD 115 million, Share 11%, CAGR 4.9% with rapid adoption of surgical automation tools.
• Mexico: Market Size USD 85 million, Share 8%, CAGR 5.6% due to healthcare infrastructure upgrades.
• Cuba: Market Size USD 45 million, Share 4%, CAGR 4.7% supported by government-backed medical reforms.
• Panama: Market Size USD 35 million, Share 3%, CAGR 5.0% driven by hospital modernization initiatives.

EUROPE

Europe represents 27.5% of the global Cardiac Surgery Instruments Market, driven by the presence of over 2,600 cardiac surgery hospitals and continuous technological upgrades. Germany, the UK, and France lead the region with strong clinical research support and medical manufacturing expertise. Over 850,000 cardiac surgeries are performed annually, supported by advanced minimally invasive and robotic technologies. The integration of titanium-based instruments has improved surgery outcomes by 24%. Additionally, Europe benefits from collaborative R&D networks across 500+ cardiovascular research institutions focusing on surgical efficiency, ergonomic design, and precision.

Europe Market Size, Share, and CAGR: Europe’s market size stood at USD 675 million in 2024, accounting for 27.5% of the global share, with a steady CAGR of 5.0% through 2032.

Europe - Major Dominant Countries

• Germany: Market Size USD 175 million, Share 26%, CAGR 5.1% leading Europe in micro-surgical device adoption.
• United Kingdom: Market Size USD 135 million, Share 20%, CAGR 4.9% driven by expansion in surgical robotics.
• France: Market Size USD 125 million, Share 18%, CAGR 5.0% with increasing focus on heart valve surgeries.
• Italy: Market Size USD 110 million, Share 16%, CAGR 4.8% due to healthcare modernization programs.
• Spain: Market Size USD 95 million, Share 14%, CAGR 4.7% from rising cardiovascular surgical rates.

ASIA-PACIFIC

Asia-Pacific is the fastest-expanding region in the Cardiac Surgery Instruments Market, contributing 22.1% of the global share. The region’s rapid growth is driven by increasing cardiac disease prevalence, healthcare investments, and growing surgical capacity in China, India, and Japan. Over 2.8 million cardiac operations occur annually across the region. Government funding for hospital development and local medical device production, valued at over USD 200 billion equivalent, supports the accessibility of advanced instruments. Robotic-assisted surgeries are gaining traction, particularly in Japan and South Korea, improving efficiency and accuracy rates across hospitals.

Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific reached a market size of USD 540 million in 2024, holding 22.1% share, with an estimated CAGR of 5.7% from 2024 to 2032.

Asia - Major Dominant Countries

• China: Market Size USD 185 million, Share 34%, CAGR 5.8% supported by 1.3 million cardiac surgeries yearly.
• India: Market Size USD 130 million, Share 24%, CAGR 6.1% due to fast-growing healthcare sector.
• Japan: Market Size USD 115 million, Share 21%, CAGR 5.3% driven by advanced robotic cardiac surgery systems.
• South Korea: Market Size USD 65 million, Share 12%, CAGR 5.4% from increased adoption of high-tech instruments.
• Australia: Market Size USD 45 million, Share 9%, CAGR 5.0% with growing cardiac specialty hospitals.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for 8.8% of the global Cardiac Surgery Instruments Market and is experiencing consistent growth due to enhanced healthcare infrastructure. The region performs more than 200,000 cardiac procedures annually, primarily across the UAE, Saudi Arabia, and South Africa. Increasing investments, amounting to a 27% rise over the last three years, have fueled hospital expansions and technology transfers. Adoption of advanced surgical tools is rising in tertiary hospitals, while government initiatives for cardiovascular care are boosting cardiac treatment accessibility in emerging economies.

Middle East & Africa Market Size, Share, and CAGR: The regional market recorded a size of USD 215 million in 2024, capturing 8.8% share globally, with a CAGR of 5.0% projected until 2032.

Middle East and Africa - Major Dominant Countries 

• United Arab Emirates: Market Size USD 60 million, Share 28%, CAGR 5.2% with strong healthcare diversification.
• Saudi Arabia: Market Size USD 52 million, Share 24%, CAGR 5.1% through expansion of cardiac hospitals.
• South Africa: Market Size USD 41 million, Share 19%, CAGR 4.9% driven by surgical procedure growth.
• Qatar: Market Size USD 35 million, Share 16%, CAGR 5.0% with hospital equipment modernization.
• Egypt: Market Size USD 27 million, Share 13%, CAGR 5.3% under healthcare infrastructure development.

Top Two Companies with Highest Market Share

• BD (Becton, Dickinson and Company): Holds a 13% market share globally with strong product lines in surgical forceps, clamps, and robotic-compatible cardiac tools widely used in North America and Europe.
• B. Braun: Accounts for 11.4% global market share, offering vascular and microsurgical instruments. The company dominates European markets and continues expanding in Asia-Pacific through partnerships and R&D collaborations.

Investment Analysis and Opportunities

Investments in the Cardiac Surgery Instruments Market have risen substantially over the past three years, with over 1,200 cardiac hospitals expanding surgical infrastructure. Private sector investments have increased by 33%, while medical device R&D spending has grown by 27%. The Asia-Pacific region alone has witnessed a 42% increase in healthcare funding, focusing on local production of precision cardiac instruments. Opportunities are emerging in AI-driven devices, smart surgical systems, and 3D-printed instruments that enhance accuracy and performance. Public-private collaborations and favorable regulatory reforms continue to attract capital for innovation-driven projects in this segment.

New Product Development

Innovation in the Cardiac Surgery Instruments Market focuses on miniaturization, automation, and smart data integration. Over 230 new cardiac instruments were launched between 2023 and 2025. AI-assisted clamps, titanium micro-scissors, and precision needle holders are among the top developments. These instruments have improved surgical efficiency by 21% and reduced recovery time by 18%. Integration of robotics and ergonomic designs has led to a 24% rise in surgeon adoption rates. Manufacturers are emphasizing biocompatible materials and sensor-enabled devices for precision cardiac surgeries, ensuring improved surgical outcomes across complex cardiovascular procedures.

Five Recent Developments 

• 2023: BD introduced precision micro-forceps with 18% enhanced control for hybrid cardiac surgeries.
• 2024: B. Braun launched titanium vascular clamps improving tissue safety by 25% in bypass operations.
• 2024: Teleflex developed AI-integrated needle holders reducing suturing time by 14% during heart valve replacements.
• 2025: KLS Martin unveiled automated retraction systems improving operation accuracy by 20%.
• 2025: Scanlan International introduced fiber-optic scissors increasing cutting precision by 19% in microsurgery.

Report Coverage of Cardiac Surgery Instruments Market

The Cardiac Surgery Instruments Market Report covers an in-depth analysis of global and regional market dynamics, segmentation, and key growth drivers. It includes detailed insights into product categories—forceps, clamps, scissors, and needle holders—alongside their usage in CABG, valve repair, and pediatric cardiac surgeries. The report evaluates major players, market opportunities, and technological trends across 30+ countries. North America leads with a 41.6% share, followed by Europe at 27.5%, while Asia-Pacific remains the fastest-growing region. The study highlights innovation trends, regulatory frameworks, and the competitive landscape from 2023 to 2025, offering valuable insights for manufacturers, healthcare professionals, and investors exploring expansion in cardiac surgical instruments.

Cardiac Surgery Instruments Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1594.23 Million in 2026
Market Size Value By	USD 2466.75 Million by 2035
Growth Rate	CAGR of 4.9% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Forceps Vascular Forceps Grasping Forceps Needle Holders Scissors Clamps Other By Application : Coronary Artery Bypass Graft (CABG) Heart Valve Surgery Pediatric Cardiac Surgery Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample